{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:58:35Z","timestamp":1792036715490,"version":"4.4.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100011025","name":"Government of Western Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013741","name":"Royal Australian and New Zealand College of Radiologists","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013741","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001111","name":"Cancer Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001111","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jaad.2025.07.028","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T15:58:30Z","timestamp":1752767910000},"page":"1251-1260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Radiotherapy versus imiquimod for complex lentigo maligna: A phase 3 randomized clinical trial"],"prefix":"10.1016","volume":"93","author":[{"given":"Angela M.","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serigne N.","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald B.","family":"Fogarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Stretch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Fernandez-Penas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard C.W.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Foote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Peter","family":"Soyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Ruben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Mar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyro","family":"Festa-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Wratten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Hogarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Collgros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Glanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna Melhoranse","family":"Gouveia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Scolyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine T.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Guitera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2025.07.028_bib1","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1365-2133.2012.11064.x","article-title":"Changes in the site distribution of common melanoma sub-types in Queensland, Australia over time: implications for public health campaigns","volume":"168","author":"Youl","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2025.07.028_bib2","first-page":"35","article-title":"Exploring melanoma shifts: a two-decade analysis in New Zealand","volume":"137","author":"Wen","year":"2024","journal-title":"N Z Med J"},{"key":"10.1016\/j.jaad.2025.07.028_bib3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2165\/00128071-200506030-00002","article-title":"Lentigo maligna : prognosis and treatment options","volume":"6","author":"Stevenson","year":"2005","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2025.07.028_bib4","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/00000372-199612000-00002","article-title":"Melanoma in situ versus melanocytic hyperplasia in sun-damaged skin. Assessment of the significance of histopathologic criteria fornbsp;differential diagnosis","volume":"18","author":"Weyers","year":"1996","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaad.2025.07.028_bib5","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0190-9622(96)90121-8","article-title":"The starburst giant cell is useful for distinguishing lentigo maligna from photodamaged skin","volume":"35","author":"Cohen","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.07.028_bib6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0190-9622(94)70140-7","article-title":"Margin control for lentigo maligna","volume":"31","author":"Robinson","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.07.028_bib7","first-page":"493","article-title":"Lentigo maligna\/lentigo maligna melanoma: current state of diagnosis and treatment","volume":"32","author":"McKenna","year":"2006","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2025.07.028_bib8","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/jdv.17135","article-title":"Lentiginous melanoma (lentigo maligna and lentigo maligna melanoma) in Australia: clinicopathological characteristics, management and recurrence rates after 10-year follow-up at a tertiary centre","volume":"35","author":"Collgros","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2025.07.028_bib9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/bjd.12611","article-title":"Radiotherapy for lentigo maligna: a literature review and recommendations for treatment","volume":"170","author":"Fogarty","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2025.07.028_bib10","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13014-020-01615-2","article-title":"Radiotherapy for lentigo maligna and lentigo maligna melanoma - a systematic review","volume":"15","author":"Hendrickx","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.jaad.2025.07.028_bib11","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/ajd.13720","article-title":"A practical guide on the use of imiquimod cream to treat lentigo maligna","volume":"62","author":"Guitera","year":"2021","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaad.2025.07.028_bib12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s40273-017-0545-x","article-title":"A review of generic preference-based measures for use in cost-effectiveness models","volume":"35","author":"Brazier","year":"2017","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jaad.2025.07.028_bib13","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/01.mlr.0000254515.63841.81","article-title":"Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients","volume":"45","author":"Pickard","year":"2007","journal-title":"Med Care"},{"key":"10.1016\/j.jaad.2025.07.028_bib14","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jval.2016.11.015","article-title":"Instrument-defined estimates of the minimally important difference for EQ-5D-5L index scores","volume":"20","author":"McClure","year":"2017","journal-title":"Value Health"},{"key":"10.1016\/j.jaad.2025.07.028_bib15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jclinepi.2021.10.019","article-title":"Small differences in EQ-5D-5L health utility scores were interpreted differently between and within respondents","volume":"142","author":"McClure","year":"2022","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jaad.2025.07.028_bib16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/120347540100500202","article-title":"Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases","volume":"5","author":"Chren","year":"2001","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2025.07.028_bib17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.det.2011.11.003","article-title":"The Skindex instruments to measure the effects of skin disease on quality of life","volume":"30","author":"Chren","year":"2012","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2025.07.028_bib18","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/bjd.14788","article-title":"A systematic review of the use of quality-of-life instruments in randomized controlled trials for psoriasis","volume":"176","author":"Ali","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2025.07.028_bib19","first-page":"20","article-title":"Outcome measurement instruments used to evaluate dermatologic adverse events in cancer trials: a systematic review","volume":"20","author":"Shaigany","year":"2024","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2025.07.028_bib20","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/biomet\/75.4.800","article-title":"A sharper Bonferroni procedure for multiple tests of significance","volume":"75","author":"Hochberg","year":"1988","journal-title":"Biometrika"},{"key":"10.1016\/j.jaad.2025.07.028_bib21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaad.2011.06.029","article-title":"Grenz ray treatment of lentigo maligna and early lentigo maligna melanoma","volume":"67","author":"Hedblad","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.07.028_bib22","doi-asserted-by":"crossref","first-page":"884","DOI":"10.2340\/00015555-3241","article-title":"Effectiveness of 5% topical imiquimod for lentigo maligna treatment","volume":"99","author":"Tio","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2025.07.028_bib23","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1007\/s13555-023-00993-1","article-title":"Topical treatment of melanoma in situ, lentigo maligna, and lentigo maligna melanoma with imiquimod cream: a systematic review of the literature","volume":"13","author":"Vaienti","year":"2023","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.jaad.2025.07.028_bib24","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/bjd.12839","article-title":"Surveillance for treatment failure of lentigo maligna with dermoscopy and in vivo confocal microscopy: new descriptors","volume":"170","author":"Guitera","year":"2014","journal-title":"Br J Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225024818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225024818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:56:12Z","timestamp":1772794572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962225024818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0190962225024818"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2025.07.028","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiotherapy versus imiquimod for complex lentigo maligna: A phase 3 randomized clinical trial","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2025.07.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}